Sinotherapeutics Inc. (SHA:688247)
China
· Delayed Price · Currency is CNY 10.90
-0.03 (-0.27%)
At close: Jul 11, 2025, 2:57 PM CST
Sinotherapeutics Revenue
Sinotherapeutics had revenue of 108.93M CNY in the quarter ending March 31, 2025, a decrease of -2.23%. This brings the company's revenue in the last twelve months to 509.13M, up 38.03% year-over-year. In the year 2024, Sinotherapeutics had annual revenue of 511.62M with 70.61% growth.
Revenue (ttm)
509.13M
Revenue Growth
+38.03%
P/S Ratio
9.61
Revenue / Employee
1.63M
Employees
312
Market Cap
4.89B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |